Utilization of potent CYP1A2 inhibitors ought to be discontinued before initiating pirfenidone and averted in the course of therapy; if strong CYP1A2 inhibitors are the sole drug of choice, dosage reductions are advised Prevent; coadministration of pirfenidone and reasonable CYP1A2 inhibitors result in reasonably improved exposure to pirfenidone; if not https://pikm766yju9.fliplife-wiki.com/user